Sign In
Buy KLDO
$0.0001
+0 (+0%)
At Close: Jun 02, 2026
Kaleido Biosciences Earnings Calls
Mar 31, 2026
| Release date | May 05, 2026 |
| EPS estimate | -$0.580 |
| EPS actual | - |
| Revenue estimate | 91.667K |
| Revenue actual | - |
Dec 31, 2025
| Release date | Mar 04, 2026 |
| EPS estimate | -$0.594 |
| EPS actual | - |
| Revenue estimate | 9M |
| Revenue actual | - |
Mar 30, 2023
| Release date | May 22, 2023 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2022
| Release date | Mar 27, 2023 |
| EPS estimate | -$0.510 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Kaleido Biosciences
Below you can see how KLDO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2022
| Release date | Mar 27, 2023 |
| Price on release | $0.0002 |
| EPS estimate | -$0.510 |
| EPS actual | - |
| Date | Price |
|---|---|
| Mar 21, 2023 | $0.0002 |
| Mar 22, 2023 | $0.0002 |
| Mar 23, 2023 | $0.0002 |
| Mar 24, 2023 | $0.0002 |
| Mar 27, 2023 | $0.0002 |
| Mar 28, 2023 | $0.0002 |
| Mar 29, 2023 | $0.0002 |
| Mar 30, 2023 | $0.0002 |
| Mar 31, 2023 | $0.0002 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Mar 30, 2023
| Release date | May 22, 2023 |
| Price on release | $0.00001 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| May 16, 2023 | $0.0001 |
| May 17, 2023 | $0.0001 |
| May 18, 2023 | $0.0001 |
| May 19, 2023 | $0.00001 |
| May 22, 2023 | $0.00001 |
| May 23, 2023 | $0.00001 |
| May 24, 2023 | $0.00001 |
| May 25, 2023 | $0.00001 |
| May 26, 2023 | $0.00001 |
| 4 days before | -90.00% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -90.00% |
Dec 31, 2025
| Release date | Mar 04, 2026 |
| Price on release | $0.0001 |
| EPS estimate | -$0.594 |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 26, 2026 | $0.0001 |
| Feb 27, 2026 | $0.0001 |
| Mar 02, 2026 | $0.0001 |
| Mar 03, 2026 | $0.0001 |
| Mar 04, 2026 | $0.0001 |
| Mar 05, 2026 | $0.0001 |
| Mar 06, 2026 | $0.0001 |
| Mar 09, 2026 | $0.0001 |
| Mar 10, 2026 | $0.0001 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Mar 31, 2026
| Release date | May 05, 2026 |
| Price on release | $0.0001 |
| EPS estimate | -$0.580 |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 29, 2026 | $0.0001 |
| Apr 30, 2026 | $0.0001 |
| May 01, 2026 | $0.0001 |
| May 04, 2026 | $0.0001 |
| May 05, 2026 | $0.0001 |
| May 06, 2026 | $0.0001 |
| May 07, 2026 | $0.0001 |
| May 08, 2026 | $0.0001 |
| May 11, 2026 | $0.0001 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Kaleido Biosciences Earnings History
Earnings Calendar
FAQ
When is the earnings report for KLDO?
Kaleido Biosciences Inc. (KLDO) has scheduled its earnings report for Aug 12, 2026 after the markets close.
What is the KLDO price-to-earnings (P/E) ratio?
KLDO P/E ratio as of Jun 02, 2026 (TTM) is -0.00004636274256.
What is the KLDO EPS forecast?
The forecasted EPS (Earnings Per Share) for Kaleido Biosciences Inc. (KLDO) for the first fiscal quarter 2026 is -$0.580.
What are Kaleido Biosciences Inc.'s retained earnings?
On its balance sheet, Kaleido Biosciences Inc. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
